معرفی
Professor Alison Yarnall is a neurology researcher at Newcastle University, specializing in Parkinson's disease, cognitive impairment, and neurodegenerative disorders. Her work focuses on gait analysis, wearable sensor technologies, and clinical outcomes in neurodegenerative conditions. She leads the Mobilise-D consortium and collaborates on studies like the Exenatide-PD3 clinical trial. Her research addresses delirium detection, cholinergic dysfunction, and motor symptom management in Parkinson's patients. She has pioneered real-world gait monitoring and validated digital health tools for medication adherence. Her multidisciplinary approach integrates engineering, neuroscience, and clinical practice to improve diagnostic accuracy and therapeutic interventions.
- Affiliations: Newcastle University (Neurology focus)
- Key projects: Mobilise-D, ICICLE-PD cohort studies
- Research emphases: Wearable sensors, Parkinson's biomarkers, cognitive decline prediction
Her research interests include the interplay between cholinergic systems and postural control, the role of digital mobility outcomes in clinical trials, and the neuroimaging correlates of cognitive impairment. She has published extensively on gait analysis, delirium in Parkinson's patients, and the application of machine learning in neurological monitoring.
Notable contributions include developing energy-based indices for motor state assessment and advancing Delphi-method protocols for patient-centered digital health design. Her work bridges clinical practice and technological innovation, aiming to improve patient outcomes through precise monitoring and early intervention strategies.